AU2022257111A1 - Hyperactivators of mammalian dendritic cells - Google Patents

Hyperactivators of mammalian dendritic cells Download PDF

Info

Publication number
AU2022257111A1
AU2022257111A1 AU2022257111A AU2022257111A AU2022257111A1 AU 2022257111 A1 AU2022257111 A1 AU 2022257111A1 AU 2022257111 A AU2022257111 A AU 2022257111A AU 2022257111 A AU2022257111 A AU 2022257111A AU 2022257111 A1 AU2022257111 A1 AU 2022257111A1
Authority
AU
Australia
Prior art keywords
composition
lpc
acyl chain
agonist
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022257111A
Other languages
English (en)
Inventor
Jonathan Chow
Kelsey K FINN
Emily GOSSELIN
Dania ZHIVAKI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corner Therapeutics Inc
Original Assignee
Corner Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corner Therapeutics Inc filed Critical Corner Therapeutics Inc
Publication of AU2022257111A1 publication Critical patent/AU2022257111A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AU2022257111A 2021-04-12 2022-04-11 Hyperactivators of mammalian dendritic cells Pending AU2022257111A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163173958P 2021-04-12 2021-04-12
US63/173,958 2021-04-12
US202163246740P 2021-09-21 2021-09-21
US63/246,740 2021-09-21
PCT/US2022/071664 WO2022221827A2 (en) 2021-04-12 2022-04-11 Hyperactivators of mammalian dendritic cells

Publications (1)

Publication Number Publication Date
AU2022257111A1 true AU2022257111A1 (en) 2023-10-26

Family

ID=81749254

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022257111A Pending AU2022257111A1 (en) 2021-04-12 2022-04-11 Hyperactivators of mammalian dendritic cells

Country Status (7)

Country Link
US (1) US20240197869A1 (https=)
EP (1) EP4322999A2 (https=)
JP (1) JP2024514026A (https=)
AU (1) AU2022257111A1 (https=)
CA (1) CA3215072A1 (https=)
IL (1) IL307508A (https=)
WO (1) WO2022221827A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118843455A (zh) * 2022-02-07 2024-10-25 科纳治疗公司 免疫原性mRNA递送媒介物
TW202342094A (zh) * 2022-02-07 2023-11-01 美商科納療法股份有限公司 高度活化之脂質奈米粒子
WO2024159157A2 (en) * 2023-01-27 2024-08-02 Corner Therapeutics, Inc. Phospholipid analogs for hyperactivation of mammalian dendritic cells
TW202502377A (zh) * 2023-03-13 2025-01-16 美商科納療法股份有限公司 旁觀者抗原增強之腫瘤細胞溶解物免疫原性
WO2025221606A1 (en) * 2024-04-16 2025-10-23 Corner Therapeutics, Inc. Lipids for hyperactivation of mammalian dendritic cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2836828A1 (fr) * 2002-03-11 2003-09-12 Bio Merieux Utilisation de l-alpha-lysophosphatidylcholine pour obtenir la differenciation de monocytes en cellules dendritiques matures in vitro
WO2004091603A1 (fr) * 2003-04-07 2004-10-28 Clinigenetics Utilisation d’un ester de dha pour le traitement des malades cardiovasculaires
CN102293743B (zh) * 2010-06-24 2013-09-18 辽宁成大生物股份有限公司 一种脂质微球组合物
KR101951933B1 (ko) * 2013-03-12 2019-02-25 주식회사 아리바이오 라이소포스파티딜콜린 또는 이의 유도체를 포함하는 지질나노물질 및 이의 제조방법

Also Published As

Publication number Publication date
EP4322999A2 (en) 2024-02-21
WO2022221827A3 (en) 2022-12-29
US20240197869A1 (en) 2024-06-20
JP2024514026A (ja) 2024-03-27
CA3215072A1 (en) 2022-10-20
WO2022221827A2 (en) 2022-10-20
IL307508A (en) 2023-12-01

Similar Documents

Publication Publication Date Title
US20240197869A1 (en) Hyperactivators of mammalian dendritic cells
US12258581B2 (en) T cell manufacturing compositions and methods
JP2021181462A (ja) ポリｉ：ｃポリヌクレオチドアジュバント及び脂質系アジュバントを含むアジュバント系及び水を含まないワクチン組成物
Yan et al. Nano-adjuvants and immune agonists promote antitumor immunity of peptide amphiphiles
CN118215501A (zh) 哺乳动物树突细胞的超激活剂
US20250134994A1 (en) Immunogenic mrna delivery vehicles
CA3104182C (en) Immunomodulatory peptides and methods for modulating the immune system in a subject
US20250127868A1 (en) Hyperactivating lipid nanoparticles
WO2025221606A1 (en) Lipids for hyperactivation of mammalian dendritic cells
TW202502377A (zh) 旁觀者抗原增強之腫瘤細胞溶解物免疫原性
WO2024159157A2 (en) Phospholipid analogs for hyperactivation of mammalian dendritic cells
CN118922179A (zh) 超激活脂质纳米颗粒
TW202400253A (zh) 編碼具持續性活性之環gmp-amp合成酶之核酸及用於彼等之免疫原性遞送載體
RU2793344C2 (ru) Композиции и способы для производства т-клеток
Prasit Harnessing iNKT cells to improve in situ vaccination for cancer therapy